C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98%
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

CytoTools AG
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CytoTools AG
Operating Expenses Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
C
CytoTools AG
XETRA:T5O
Operating Expenses
-€706k
CAGR 3-Years
20%
CAGR 5-Years
9%
CAGR 10-Years
2%
BioNTech SE
NASDAQ:BNTX
Operating Expenses
-€2.3B
CAGR 3-Years
-66%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Operating Expenses
-€611.1m
CAGR 3-Years
-25%
CAGR 5-Years
-37%
CAGR 10-Years
-25%
Immatics NV
NASDAQ:IMTX
Operating Expenses
-€155.7m
CAGR 3-Years
-16%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Expenses
-€147.4m
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
1%
Formycon AG
XETRA:FYB
Operating Expenses
-€23.3m
CAGR 3-Years
-18%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is CytoTools AG's Operating Expenses?
Operating Expenses
-706k EUR

Based on the financial report for Jun 30, 2023, CytoTools AG's Operating Expenses amounts to -706k EUR.

What is CytoTools AG's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
2%

Over the last year, the Operating Expenses growth was 63%. The average annual Operating Expenses growth rates for CytoTools AG have been 20% over the past three years , 9% over the past five years , and 2% over the past ten years .

Back to Top